RedHill Biopharma Ltd. - Depositary Receipt (Common Stock) - Neraca (Quarterly)

RedHill Biopharma Ltd. - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US7574682024
€0,10 ↓ -0,05 (-32,68%)
2023-03-22
HARGA SAHAM
Neraca (Quarterly)

RedHill Biopharma Ltd. - Depositary Receipt (Common Stock) Neraca menunjukkan saldo akun perusahaan pada waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Aset Tetap (APD), Persediaan, Barang Tak Berwujud, Kewajiban, Kewajiban Lancar, Hutang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Treasury, dan Ekuitas Pemegang Saham.

Semua angka dikalikan 1,000,000.00 kecuali per unit saham.

2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
12-31
Uang tunai 23 29 29 27 15 20 18 7 6 6 7 7 2 2 3 3 1
Mengubah (%) 26,75 -2,13 -6,44 -43,66 31,33 -12,00 -60,18 -20,40 0,00 30,67 0,00 -74,14 0,00 52,28 0,00 -52,97
Aset Lancar 83 89 73 91 83 86 47 27 16 16 16 16 12 12 13 13 7
Mengubah (%) 7,26 -18,59 25,75 -8,95 3,37 -45,85 -41,86 -40,32 0,00 -2,71 0,00 -24,15 0,00 5,41 0,00 -48,00
Aktiva 186 181 167 168 157 159 59 35 23 23 22 22 18 18 18 18 25
Mengubah (%) -2,76 -7,80 0,55 -6,41 1,07 -62,97 -40,45 -34,22 0,00 -4,44 0,00 -18,08 0,00 1,84 0,00 37,93
Kewajiban 175 172 172 180 203 207 57 32 21 21 22 22 23 23 23 23 21
Mengubah (%) -1,42 -0,01 4,42 12,96 1,99 -72,58 -44,46 -33,54 0,00 4,70 0,00 3,47 0,00 0,27 0,00 -7,50
Ekuitas 12 9 -5 -12 -46 -48 2 3 2 2 0 0 -5 -5 -4 -4 4
Mengubah (%) -23,15 -159,08 127,73 285,49 5,16 -104,14 73,20 -40,39 0,00 -97,05 0,00 -7.777,05 -0,00 -5,79 -0,00 -196,74
Kewajiban dan Ekuitas Saham 186 181 167 168 157 159 59 35 23 23 22 22 18 18 18 18 25
Mengubah (%) -2,76 -7,80 0,55 -6,41 1,07 -62,97 -40,45 -34,22 0,00 -4,44 0,00 -18,08 0,00 1,84 0,00 37,93

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:RDHL US$1,03
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista